RTW Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,582,396
Closed -$153M 135
2021
Q3
$153M Buy
7,582,396
+60,537
+0.8% +$1.67M 2.31% 13
2021
Q2
$281M Buy
7,521,859
+58,568
+0.8% +$1.8M 4.24% 4
2021
Q1
$191M Buy
7,463,291
+209,434
+3% +$5.35M 2.98% 7
2020
Q4
$160M Buy
7,253,857
+26,444
+0.4% +$582K 2.68% 8
2020
Q3
$130M Buy
7,227,413
+74,495
+1% +$1.54M 3.13% 6
2020
Q2
$182M Buy
7,152,918
+189,783
+3% +$4.09M 5.11% 4
2020
Q1
$128M Buy
6,963,135
+1,088,906
+19% +$21.2M 5.51% 4
2019
Q4
$129M Sell
5,874,229
-328,196
-5% -$6.6M 4.88% 4
2019
Q3
$89.1M Buy
6,202,425
+50,322
+0.8% +$719K 5.3% 4
2019
Q2
$96.9M Sell
6,152,103
-70,933
-1% -$965K 5.18% 4
2019
Q1
$91.2M Buy
6,223,036
+315,948
+5% +$3.63M 6.22% 3
2018
Q4
$63.1M Buy
5,907,088
+445,964
+8% +$5.87M 5.8% 4
2018
Q3
$83.3M Buy
5,461,124
+416,311
+8% +$6.06M 4.99% 5
2018
Q2
$61.8M Buy
5,044,813
+15,351
+0.3% +$193K 4.46% 6
2018
Q1
$48.1M Sell
5,029,462
-6,200
-0.1% -$66.8K 4.58% 7
2017
Q4
$44.1M Buy
5,035,662
+2,956,671
+142% +$21.8M 7.37% 5
2017
Q3
$12M Hold
2,078,991
2.08% 15
2017
Q2
$6.59M Buy
2,078,991
+16,000
+0.8% +$50.5K 1.39% 19
2017
Q1
$7.01M Buy
2,062,991
+19,775
+1% +$55.7K 1.85% 17
2016
Q4
$5.88M Buy
2,043,216
+16,322
+0.8% +$58K 2.22% 13
2016
Q3
$11.9M Hold
2,026,894
3.62% 8
2016
Q2
$6.08M Hold
2,026,894
2.08% 15
2016
Q1
$10.9M Buy
2,026,894
+14,232
+0.7% +$89.8K 3.96% 8
2015
Q4
$23.9M Buy
2,012,662
+7,424
+0.4% +$84.9K 7.78% 5
2015
Q3
$16.5M Buy
2,005,238
+725,352
+57% +$8.38M 5.17% 8
2015
Q2
$17.9M Buy
1,279,886
+288,905
+29% +$5.3M 5.3% 8
2015
Q1
$23.8M Sell
990,981
-125,000
-11% -$2.81M 10.75% 3
2014
Q4
$18.4M Buy
+1,115,981
New +$12.9M 6.8% 8

Other funds holding DRNA